See also this year's filing and all EDGAR filings for this company.
PDF Report 0001513525_2026_Adial_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001513525, Adial Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,180,883 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,784 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 489,700 |
| 4 | LiabilitiesCurrent | 1,396,909 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,147,274 |
| 9 | ResearchAndDevelopmentExpense | 2,648,734 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,457,830 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,673,367 |
| 1 | Liabilities | 1,396,909 |
| 2 | Expenses | 7,796,008 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 5,276,458 |
| 5 | NetIncome | -10,253,838 |
| 6 | ComprehensiveNetIncome | -10,253,838 |
| 7 | BaseVar | 9,162,057 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.309 |
| 9 | EconomicCapitalRatio | 1.71 |
Edgar->Model Mapping
Feature Distribution
Change over Time
